European Archives - Page 1269 of 1313 - European Medical Journal

How I Treat: Coronary Heart Disease: The Pleiotropic Effects of Statins

Cardiovascular (CV) diseases currently represent the first cause of death in industrialised countries with coronary heart disease (CHD) corresponding to…

EMJ Cardiology 3.1 2015

The field of Cardiology is one which has rapidly evolved over the last few decades; advances in procedures, diagnosis, and treatments have progressively…

EMJ

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

DEVELOPMENT of treatments for leukaemia and lymphoma could be aided by a new computer model that simulates the development of blood cells…

EMJ

Combination Therapy Trial for Breast Cancer

BREAST cancer patients with small node-negative HER2-positive tumours achieved 3-year survival approaching 100% with adjuvant paclitaxel and trastuzumab…

EMJ

Anti-Cancer Transformers: The next Generation Self-Assembling Arsenal

PROGRAMMABLE biomaterial that is capable of spontaneously assembling into a fighting structure once injected into a living body has the potential to…

EMJ

Education of Medical Students in the Robotic Surgery Operating Room

Starting from the first year of medical school, our medical students have the opportunity to observe robotic urological procedures in the operating room…

EMJ

InflectraTM (Infliximab) Patient Registry Reports Interim Results in the Treatment of Inflammatory Bowel Disease

Data have been presented on the use of Hospira’s Inflectra (infliximab) at the European Crohn’s and Colitis Organisation Inflammatory Bowel Diseases (ECCO-ibd) conference.

EMJ

Serving the Underserved—Making Strides to Improve Women’s Cardiovascular Health

At the age of four, my daughter Bek began to have troubles with fatigue. Her mother noted that she was drinking more water and seemed to have to go to…

EMJ

ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma

Dr Andrew Davies (University of Southampton, Southampton, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses a phase II/III…

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society…